Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Long, Jason
Wright, Edward
Molesti, Eleonora
Temperton, Nigel
and
Barclay, Wendy
2015.
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.
F1000Research,
Vol. 4,
Issue. ,
p.
30.
Wong, Samson Sai-Yin
and
Wong, Sally Cheuk-Ying
2015.
Ebola virus disease in nonendemic countries.
Journal of the Formosan Medical Association,
Vol. 114,
Issue. 5,
p.
384.
Long, Jason
Wright, Edward
Molesti, Eleonora
Temperton, Nigel
and
Barclay, Wendy
2015.
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.
F1000Research,
Vol. 4,
Issue. ,
p.
30.
Yen, Hui-Ling
2016.
Current and novel antiviral strategies for influenza infection.
Current Opinion in Virology,
Vol. 18,
Issue. ,
p.
126.
Zaraket, Hassan
and
Saito, Reiko
2016.
Japanese Surveillance Systems and Treatment for Influenza.
Current Treatment Options in Infectious Diseases,
Vol. 8,
Issue. 4,
p.
311.
Venkatesan, Sudhir
Cox, Rebecca J.
Nguyen-Van-Tam, Jonathan S.
and
Myles, Puja R.
2016.
SARS, MERS and other Viral Lung Infections.
FURUTA, Yousuke
KOMENO, Takashi
and
NAKAMURA, Takaaki
2017.
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
Proceedings of the Japan Academy, Series B,
Vol. 93,
Issue. 7,
p.
449.
Farrukee, Rubaiyea
and
Hurt, Aeron C.
2017.
Antiviral Drugs for the Treatment and Prevention of Influenza.
Current Treatment Options in Infectious Diseases,
Vol. 9,
Issue. 3,
p.
318.
Zhang, Tao
Zhai, Min
Ji, Jianbo
Zhang, Jian
Tian, Ye
and
Liu, Xinyong
2017.
Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.
Bioorganic & Medicinal Chemistry Letters,
Vol. 27,
Issue. 11,
p.
2364.
Beylkin, Diane
Kumar, Gyanendra
Zhou, Wei
Park, Jaehyeon
Jeevan, Trushar
Lagisetti, Chandraiah
Harfoot, Rhodri
Webby, Richard J.
White, Stephen W.
and
Webb, Thomas R.
2017.
Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease.
Scientific Reports,
Vol. 7,
Issue. 1,
Singh, Raj Kumar
Dhama, Kuldeep
Malik, Yashpal Singh
Ramakrishnan, Muthannan Andavar
Karthik, Kumaragurubaran
Khandia, Rekha
Tiwari, Ruchi
Munjal, Ashok
Saminathan, Mani
Sachan, Swati
Desingu, Perumal Arumugam
Kattoor, Jobin Jose
Iqbal, Hafiz M.N.
and
Joshi, Sunil Kumar
2017.
Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey.
Veterinary Quarterly,
Vol. 37,
Issue. 1,
p.
98.
Koszalka, Paulina
Tilmanis, Danielle
and
Hurt, Aeron C.
2017.
Influenza antivirals currently in late‐phase clinical trial.
Influenza and Other Respiratory Viruses,
Vol. 11,
Issue. 3,
p.
240.
Delang, Leen
Abdelnabi, Rana
and
Neyts, Johan
2018.
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
Antiviral Research,
Vol. 153,
Issue. ,
p.
85.
Pires de Mello, Camilly P.
Tao, Xun
Kim, Tae Hwan
Vicchiarelli, Michael
Bulitta, Jürgen B.
Kaushik, Ajeet
and
Brown, Ashley N.
2018.
Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
Antimicrobial Agents and Chemotherapy,
Vol. 62,
Issue. 9,
Xiao, Julie Huiyuan
Rijal, Pramila
Schimanski, Lisa
Tharkeshwar, Arun Kumar
Wright, Edward
Annaert, Wim
Townsend, Alain
and
García-Sastre, Adolfo
2018.
Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.
Journal of Virology,
Vol. 92,
Issue. 4,
Dhama, Kuldeep
Karthik, Kumaragurubaran
Khandia, Rekha
Chakraborty, Sandip
Munjal, Ashok
Latheef, Shyma K.
Kumar, Deepak
Ramakrishnan, Muthannan Andavar
Malik, Yashpal Singh
Singh, Rajendra
Malik, Satya Veer Singh
Singh, Raj Kumar
and
Chaicumpa, Wanpen
2018.
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
Frontiers in Immunology,
Vol. 9,
Issue. ,
Favié, Laurent MA
Murk, Jean-Luc
Meijer, Adam
Nijstad, A Laura
van Maarseveen, Erik M
and
Sikma, Maaike A
2018.
Pharmacokinetics of Favipiravir during Continuous Venovenous Haemofiltration in a Critically ill Patient with Influenza.
Antiviral Therapy,
Vol. 23,
Issue. 5,
p.
457.
Pires de Mello, Camilly P.
Tao, Xun
Kim, Tae Hwan
Bulitta, Jürgen B.
Rodriquez, Jaime L.
Pomeroy, Justin J.
and
Brown, Ashley N.
2018.
Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
Antimicrobial Agents and Chemotherapy,
Vol. 62,
Issue. 1,
Kasianenko, K. V.
Lvov, N. I.
Maltsev, O. V.
and
Zhdanov, K. V.
2019.
nucleoside analogues for the treatment of influenza: history and experience.
Journal Infectology,
Vol. 11,
Issue. 3,
p.
20.
Arias, Armando
2019.
Norovirus.
p.
101.